Članek
Objavljeno Dec 14, 2021
Uradna spletna stran vlade Združenih držav, NIH - Nacionalni inštituti za zdravje
(An official website of the United States government, NIH - National Institutes of Health)
Tabela 2e. Značilnosti protivirusnih zdravil, ki so odobrena ali so v ocenjevanju za zdravljenje COVID-19
(Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19)
- Remdesivir
- Ivermectin
- Nitazoxanide
Dec 14, 2021